Sansure Biotech Inc. (SHA:688289)
China · Delayed Price · Currency is CNY 18.28
+0.41 (2.29%)
Mar 27, 2026, 3:00 PM CST
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 10.26 billion as of March 27, 2026. Its market cap has decreased by -17.01% in one year.
Market Cap
10.26B
Enterprise Value
7.45B
Revenue
1.65B
Ranking
n/a
PE Ratio
52.56
Stock Price
18.28
Market Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 10.26B, a decrease of -77.90%. That is a compound annual growth rate of -23.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 10.26B | -5.50% |
| Dec 31, 2025 | 10.86B | -16.48% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenyang Xingqi Pharmaceutical | 15.45B |
| Jiangsu Hualan New Pharmaceutical Material | 13.08B |
| Micro-Tech (Nanjing) Co.,Ltd | 12.62B |
| Autek China | 12.53B |
| Tofflon Science and Technology Group | 10.36B |
| Tinavi Medical Technologies | 9.94B |
| Eyebright Medical Technology (Beijing) | 9.52B |
| Blue Sail Medical | 7.56B |